Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;9(8):839-847.
doi: 10.2217/pme.12.100.

Why personalized medicine will fail if we stay the course

Edward Ramos  1 , Shawneequa L Callier, Charles N Rotimi
Affiliations

Why personalized medicine will fail if we stay the course

Edward Ramos et al. Per Med. 2012 Nov.

Abstract

Genomic science and associated technologies are providing scientists and clinicians with novel insights that are transforming the delivery of healthcare and the overall well-being of society. However, these insights inform us that historical population sampling approaches for investigating rare and common genetic variations are not representative of the complex ancestral backgrounds of today's patients. In order for personalized medicine to be meaningful and applicable to the global populations, we will need to know how common and rare genetic variants found in different parts of the world influence health and drug response. This article demonstrates the importance of increasing ethnic and racial diversity among participants in genomic research, highlights areas of opportunity for improving our understanding of genomic diversity among populations, and provides examples of successful models that help to resolve these concerns.

Keywords: diversity; ethnicity; genomic medicine; global populations; personalized medicine.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470(7333):204–213. - PubMed

    2. ■■ The National Human Genome Research Institute recently launched a new strategic plan that describes a new vision for the future of genomic research and the path towards an era of genomic medicine.

    1. Feero WG, Guttmacher AE, Collins FS. Genomic medicine – an updated primer. N. Engl. J. Med. 2010;362(21):2001–2011. - PubMed
    1. Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA. 2007;298(14):1682–1684. - PubMed
    1. Chan IS, Ginsburg GS. Personalized medicine: progress and promise. Annu. Rev. Genom. Hum. Genet. 2011;12:217–244. - PubMed
    1. Buchanan A, Califano A, Kahn J, McPherson E, Robertson J, Brody B. Pharmacogenetics: ethical issues and policy options. Kennedy Inst. Ethics J. 2002;12(1):1–15. - PubMed

Websites

    1. CDC. Genomics and Health Impact Blog. Medications for the Masses? Pharmacogenomics is an Important Public Health Issue 2011 http://blogs.cdc.gov/genomics/2011/07/21/medications-for-the-masses-phar....
    1. US FDA. Table of Pharmacogenomic Biomarkers in Drug Labels 2012 www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm0833....
    1. Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity, 62FR58781–58790 1997 www.whitehouse.gov/omb/fedreg_1997standards/
    1. US Census Bureau. Most Children Younger Than Age 1 are Minorities, Census Bureau Reports 2012 http://www.census.gov/newsroom/releases/archives/population/cb12–90.html.
    1. 1000 Genomes Project www.1000genomes.org.

LinkOut - more resources